Initiation of SGLT2i vs GLP1-RA and incidence of AKI in persons with type 2 diabetes mellitus

被引：0
|
作者：
Jensen, Simon Kok
Heide-Jorgensen, Uffe
Andersen, Ina Trolle
Thomsen, Reimar
Christiansen, Christian Fynbo
机构：
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark
[2] Aarhus Univ Hosp, Aarhus, Denmark
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.111
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
462
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Initiation of SGLT2i vs GLP1-RA and incidence of AKI in persons with type 2 diabetes mellitus
    Jensen, Simon Kok
    Heide-Jorgensen, Uffe
    Andersen, Ina Trolle
    Thomsen, Reimar
    Christiansen, Christian Fynbo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I197 - I198
  • [2] Initiation of SGLT2i vs. GLP1-RA and the Risk of Acute Kidney Injury in Persons with Type 2 Diabetes Mellitus
    Heide-Jorgensen, Uffe
    Jensen, Simon K.
    Andersen, Ina T.
    Thomsen, Reimar W. W.
    Christiansen, Christian Fynbo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 362 - 363
  • [3] Initiation of SGLT2i Versus GLP1-RA and the Risk of Chronic Kidney Disease in Persons with Type 2 Diabetes Mellitus
    Jensen, Simon K.
    Heide-Jorgensen, Uffe
    Andersen, Ina T.
    Thomsen, Reimar W. W.
    Christiansen, Christian Fynbo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 87 - 87
  • [4] Association of formulary restrictions and initiation of an SGLT2i or GLP1-RA among Medicare beneficiaries with type 2 diabetes
    Luo, Jing
    Gabriel, Nico
    Korytkowski, Mary
    Hernandez, Inmaculada
    Gellad, Walid F.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 187
  • [5] Extraglycemic Effects of SGLT2i/GLP1-ra: A Topic Update
    Alam, Uazman
    CLINICAL THERAPEUTICS, 2024, 46 (11) : 826 - 827
  • [6] Strategies for Appropriate Selection of SGLT2-i vs. GLP1-RA in Persons with Diabetes and Cardiovascular Disease
    Dhindsa, Devinder S.
    Mehta, Anurag
    Sandesara, Pratik B.
    Thobani, Aneesha
    Brandt, Stephen
    Sperling, Laurence S.
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (09)
  • [7] Strategies for Appropriate Selection of SGLT2-i vs. GLP1-RA in Persons with Diabetes and Cardiovascular Disease
    Devinder S. Dhindsa
    Anurag Mehta
    Pratik B. Sandesara
    Aneesha Thobani
    Stephen Brandt
    Laurence S. Sperling
    Current Cardiology Reports, 2019, 21
  • [8] Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice
    Fu, Edouard L.
    Clase, Catherine M.
    Janse, Roemer J.
    Lindholm, Bengt
    Dekker, Friedo W.
    Jardine, Meg J.
    Carrero, Juan-Jesus
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 352 : 172 - 179
  • [9] Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes
    Vale, Catarina
    Lourenco, Ines Mariana
    Jordan, Gabriela
    Golovaty, Ilya
    Torres, Hugo
    Moin, Tannaz
    Buysschaert, Martin
    Neves, Joao Sergio
    Bergman, Michael
    DIABETES OBESITY & METABOLISM, 2024,
  • [10] Eligibility and Utilization of SGLT2i and GLP1-RA in T2D by Cardiovascular and Renal Indications
    Blood, Alexander
    Chang, Lee-Shing
    Colling, Caitlin A.
    Gabovitch, Daniel
    Hamersky, Carol M.
    Durden, Emily
    Holt, Cassie
    Noone, Joshua
    Cannon, Christopher P.
    Wexler, Deborah J.
    Scirica, Benjamin M.
    Waterman, Fanta
    Stern, Gretchen
    Zelle, David
    DIABETES, 2022, 71
12345